{
    "2021-12-17": [
        [
            {
                "time": "2018-03-04",
                "original_text": "The Funded: A court fight over Johnson & Johnson's $3.4B Auris Health acquisition is going forward",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Auris Health",
                        "acquisition",
                        "court fight"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-03",
                "original_text": "Stock Market Rallies After Fed Meeting, But Not For Long; Adobe, Rivian, Eli Lilly In Focus: Weekly Review",
                "features": {
                    "keywords": [
                        "Fed Meeting",
                        "rallies",
                        "Adobe",
                        "Rivian",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "automotive"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "Pharma Stock Roundup: PFE Announces Arena Buyout, LLY Ups 2021 View & More",
                "features": {
                    "keywords": [
                        "PFE",
                        "Arena Buyout",
                        "LLY",
                        "2021 View"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-10",
                "original_text": "Biogen (BIIB) to Begin Aduhelm Confirmatory Study in 2022",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Aduhelm",
                        "Confirmatory Study"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-07",
                "original_text": "Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week",
                "features": {
                    "keywords": [
                        "Bristol Myers Squibb",
                        "Eli Lilly",
                        "Pfizer",
                        "rocketed higher"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}